Cite
Levinson K, Beavis AL, Purdy C, et al. Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021;162(3):532-538doi: 10.1016/j.ygyno.2021.06.017.
Levinson, K., Beavis, A. L., Purdy, C., Rositch, A. F., Viswanathan, A., Wolfson, A. H., Kelly, M. G., Tewari, K. S., McNally, L., Guntupalli, S. R., Ragab, O., Lee, Y. C., Miller, D. S., Huh, W. K., Wilkinson, K. J., Spirtos, N. M., Van Le, L., Casablanca, Y., Holman, L. L., Waggoner, S. E., & Fader, A. N. (2021). Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecologic oncology, 162(3), 532-538. https://doi.org/10.1016/j.ygyno.2021.06.017
Levinson, Kimberly, et al. "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis." Gynecologic oncology vol. 162,3 (2021): 532-538. doi: https://doi.org/10.1016/j.ygyno.2021.06.017
Levinson K, Beavis AL, Purdy C, Rositch AF, Viswanathan A, Wolfson AH, Kelly MG, Tewari KS, McNally L, Guntupalli SR, Ragab O, Lee YC, Miller DS, Huh WK, Wilkinson KJ, Spirtos NM, Van Le L, Casablanca Y, Holman LL, Waggoner SE, Fader AN. Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis. Gynecol Oncol. 2021 Sep;162(3):532-538. doi: 10.1016/j.ygyno.2021.06.017. Epub 2021 Jul 01. PMID: 34217544; PMCID: PMC8405564.
Copy
Download .nbib